Portfolio Detail Axerion Therapeutics Inc.

Venture Portfolio

Axerion Therapeutics

CEO:
Sylvia McBrinn

Year Established:
2009

About:
Axerion Therapeutics is a private, Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.

Website:
www.axeriontherapeutics.com

CI Representative:
David Wurzer
Executive Vice President and Chief Investment Officer

back to portfolio